To investigate how chromatin architecture at the APOE locus may influence gene regulation and contribute to AD susceptibility, we employed the chromosome conformation capture (3C) assay to identify locus-specific CIs and evaluate their regulatory impact in the context of AD risk. This evidence concerns the gene APOE and Alzheimer disease.